Category Environment

Agricultural Innovation Needed In Africa, With Farmers’ Participation, WTO Panellists Say

Farmers' needs are not addressed by the current intellectual property framework or by innovation, according to panellists at the World Trade Organization Public Forum this week, and farmers should be invited to participate in international negotiations directly impacting their livelihood. Meanwhile, the African continent is seeking a way to address the food security problem, faced with a growing population and dire need to modernise their agriculture, other panellists said.

Isolated DNA Declared Patentable By US Court Of Appeals

The United States Court of Appeals for the Federal Circuit released a decision today (16 August) on the patentability of genes in yet another twist to the so-called Myriad case. At stake was the patentability of two human genes associated with hereditary breast cancer and ovarian cancer. Myriad Genetics' patents were challenged by the Association for Molecular Pathology.

Near-Final Draft Of Rio+20 Outcome Document Shows Likely Commitments

A draft of the outcome document for this week’s Rio+20 meeting in Rio de Janeiro, Brazil, said to be close to the final version, shows where governments have placed their focus. It appears that technology transfer is well-recognised, intellectual property rights to a lesser extent, but firm actions in these areas may still be to come.

Rio+20 Conference Opens With IP, Tech Transfer, Underlying Debate

As world leaders along with thousands of government, private sector and nonprofit participants, get ready to meet in Rio de Janeiro this week, 20 years after this Brazilian city hosted the historic first Earth Summit, there are fears that there may be no meaningful consensus on how the world can become more liveable and sustainable at the same time. And technology transfer, research and development, intellectual property rights are part of the debate.

US Licensing Experts: Innovation Is Still Happening, Let’s Help It Along

BOSTON - Early stage innovation is still strong in the United States, but parties need to work better together and address bottlenecks in the middle stages, a panel of university and private sector experts said this week. Meanwhile, the president of global biotechnology company Genzyme said the industry is not in crisis and the company is hopeful about its recent merger with Sanofi.